Dear Democracy Now! Visitor: We are an independent, ad-free daily news program that serves millions of viewers and listeners each month. In this US election year, Democracy Now! is more important than ever. For 20 years, we’ve put a spotlight on corporate and government abuses of power. We lift up the stories of ordinary people working to make change in extraordinary times. We do all of this with just a fraction of the budget and staff of a commercial news show. We do it without ads, corporate sponsorship or government funding. How is this possible? Only with your support. A generous funder will match your donation dollar for dollar if you donate right now. That means when you give $10, your donation will be worth $20. Pretty exciting, right? So, if you've been waiting to make your contribution to Democracy Now!, today is your day. It takes just a couple of minutes to make sure that Democracy Now! is there for you every day.

Your Donation: $

Experimental Treatment Without Consent, part 2

November 15, 1996
Story
WATCH FULL SHOW

Last month the FDA quietly abandoned a 50 year old regulation, requiring doctors to get a person’s informed consent before conducting experiments. The FDA claims the new rules benefit those needing emergency treatment. Opponents raise the specter of Nazi doctors and US radiation experiments.

Goodman speaks to Dr. Breggin in studio. He opposes this change in policy, citing the Nuremburg Code and the World Medical Association guidelines, that this is an 'assault on basic human rights.' Breggin goes on to emphasize the abuse of drug companies, and alludes to Eli Lilly’s use of homeless people for experiments.

Guests:
- Dr. Peter Breggin, director of the International Center for Study of Psychology and Psychiatry


The original content of this program is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License. Please attribute legal copies of this work to democracynow.org. Some of the work(s) that this program incorporates, however, may be separately licensed. For further information or additional permissions, contact us.